Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Imaging for lung cancer restaging.

Todd R Hazelton1, Lynn Coppage

  • 1Department of Radiology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL 33612, USA. hazelttr@moffitt.usf.edu

Seminars in Roentgenology
|May 19, 2005
PubMed
Summary

Diagnostic imaging, including CT and 18-fluoro-2-deoxyglucose positron emission tomography (FDG-PET), is crucial for lung cancer restaging. These methods help assess treatment efficacy and detect recurrent or metastatic disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Closing the Global Radiation Dose Gap in Cardiac Imaging.

AJR. American journal of roentgenology·2026
Same author

Implementation of 3D Printing in Medical Care for Preoperative Planning of Complex Ventricular Septal Defect.

Journal of radiology case reports·2022
Same author

Role of imaging in lung transplantation evaluation.

Journal of thoracic disease·2020
Same author

3-Dimensional Printed Alternative to the Standard Synthetic Flocked Nasopharyngeal Swabs Used for Coronavirus Disease 2019 Testing.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2020
Same author

Middle Lobe Torsion after Unilateral Lung Transplant.

Journal of radiology case reports·2016
Same author

Anastomotic Airway Complications After Lung Transplant: Clinical, Bronchoscopic and CT Correlation.

Journal of thoracic imaging·2016

Area of Science:

  • Oncology
  • Radiology
  • Medical Imaging

Background:

  • Diagnostic imaging is vital for monitoring lung cancer treatment response and detecting recurrence.
  • Computed tomography (CT) is the primary imaging method for restaging and surveillance.
  • 18-fluoro-2-deoxyglucose positron emission tomography (FDG-PET) shows promise in detecting residual/recurrent disease and early treatment response.

Purpose of the Study:

  • To review the role of diagnostic imaging in lung cancer restaging.
  • To highlight the utility of CT and FDG-PET in assessing treatment efficacy.
  • To discuss the detection of recurrent or metastatic neoplasm using imaging.

Main Methods:

  • Review of current literature on diagnostic imaging in lung cancer restaging.
  • Focus on the application of CT and FDG-PET.

Related Experiment Videos

  • Emphasis on differentiating disease from therapy-related changes.

    • Main Results:

    • CT is the standard for lesion evaluation during restaging and surveillance.
    • FDG-PET demonstrates potential for detecting residual/recurrent lung cancer and early treatment response.
    • Distinguishing between residual/recurrent disease and treatment effects is essential.

    Conclusions:

    • Imaging, particularly CT and FDG-PET, plays a critical role in lung cancer management post-treatment.
    • These modalities aid in evaluating treatment effectiveness and identifying disease recurrence.
    • Further research may enhance the combined use of CT and FDG-PET for improved patient outcomes.